Schizophrenia, a severe mental disorder characterized by psychosis, is managed pharmacologically with antipsychotic medications. Typical antipsychotics, like Chlorpromazine and Haloperidol, target positive symptoms but may cause extrapyramidal symptoms. Atypical antipsychotics, such as Clozapine and Risperidone, address both positive and negative symptoms with fewer EPS but increased metabolic risks. Treatment efficacy, side effects, and patient well-being are key considerations.
Show More
Schizophrenia is a chronic and severe mental disorder characterized by episodes of psychosis, including hallucinations, delusions, and disorganized thinking
Typical Antipsychotics
Typical antipsychotics, such as Chlorpromazine and Haloperidol, primarily address the positive symptoms of schizophrenia by antagonizing dopamine D2 receptors
Atypical Antipsychotics
Atypical antipsychotics, such as Clozapine and Risperidone, are effective against both positive and negative symptoms of schizophrenia by antagonizing dopamine D2 and serotonin receptors
The diagnosis of schizophrenia relies on clinical assessment as biological markers are not yet definitive, and diagnostic criteria continue to be refined for improved accuracy
Typical antipsychotics, introduced in the 1950s, are the first generation of medications used to treat schizophrenia and primarily address positive symptoms
Atypical antipsychotics, developed in the 1970s, represent the second generation of antipsychotic drugs and are effective against both positive and negative symptoms of schizophrenia
Antipsychotic medications can cause significant side effects, including extrapyramidal symptoms and metabolic complications, which require careful monitoring and management
The choice between typical and atypical antipsychotics is influenced by the individual patient's symptom profile, side effect tolerance, and overall treatment goals